Sign up to save your podcasts
Or
Share ICYMI #NCPA2025: Fair Pricing for Type 2 Diabetes Care
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
ICYMI #NCPA2025: Fair Pricing for Type 2 Diabetes Care
Coming to you from the #NCPA2025 expo floor, host John Beckner and co-host Ed Cohen talk with Brian Connelly, president and CEO of TheracosBio, about Brenzavvy (bexagliflozin), an FDA-approved oral SGLT2 inhibitor for adults with Type 2 diabetes. They discuss how the company's model bypasses PBMs to offer pharmacists and patients a fair, transparent price.
View all episodes
By National Community Pharmacists Association
5
44 ratings
Coming to you from the #NCPA2025 expo floor, host John Beckner and co-host Ed Cohen talk with Brian Connelly, president and CEO of TheracosBio, about Brenzavvy (bexagliflozin), an FDA-approved oral SGLT2 inhibitor for adults with Type 2 diabetes. They discuss how the company's model bypasses PBMs to offer pharmacists and patients a fair, transparent price.
More shows like Independent Rx Forum
View all
Planet Money
30,756 Listeners
No Such Thing As A Fish
4,860 Listeners
Up First from NPR
56,595 Listeners
What the Health? From KFF Health News
493 Listeners
Your Financial Pharmacist
171 Listeners
The Readout Loud
321 Listeners
All-In with Chamath, Jason, Sacks & Friedberg
10,024 Listeners
Catalyst Pharmacy Podcast
34 Listeners
SmartLess
58,080 Listeners
Handsome
13,480 Listeners
The Bottom Line Pharmacy Podcast: Sykes & Company, P.A.
6 Listeners
PBM Reform Podcast
3 Listeners